Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Parham Sendi

Showing results (141-150 of 161) with videos related to

Pageof 17
Sort By:
Swiss Medical Weekly|June 26, 2025
Update on prevention and antimicrobial prophylaxis of infective endocarditisMaryam Pavlicek-Bahlo, Barbara Hasse, Michelle Frank, et al.
Antibiotics (Basel, Switzerland)|October 25, 2024
Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive <i>Staphylococcus aureus</i> Infections: A Prospective Cohort StudySeverin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis, et al.
Shock (Augusta, Ga.)|February 27, 2019
Heparin-Binding Protein as a Prognostic Biomarker of Sepsis and Disease Severity at the Emergency DepartmentFredrik Kahn, Jonas Tverring, Lisa Mellhammar, et al.
The Journal of Arthroplasty|October 27, 2018
General Assembly, Treatment, Antimicrobials: Proceedings of International Consensus on Orthopedic InfectionsK Keely Boyle, Feng-Chih Kuo, Juan Pablo Horcajada, et al.
Open Forum Infectious Diseases|December 10, 2021
A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 StudyParham Sendi, Rossella Baldan, Marc Thierstein, et al.
Immunity, Inflammation and Disease|June 27, 2022
Serosurveillance after a COVID-19 vaccine campaign in a Swiss police cohortParham Sendi, Marc Thierstein, Nadja Widmer, et al.
Journal of Medical Virology|June 30, 2023
Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohortParham Sendi, Nadja Widmer, Mattia Branca, et al.
Trials|January 5, 2021
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)Pascal Urwyler, Panteleimon Charitos, Stephan Moser, et al.
Frontiers in Immunology|November 15, 2023
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trialPascal Urwyler, Marina Leimbacher, Panteleimon Charitos, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2020
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma ConcentrationsCatia Marzolini, Felix Stader, Marcel Stoeckle, et al.
Pageof 17

Showing results (141-150 of 161) with videos related to

Sort By:
Pageof 17
Swiss Medical Weekly|June 26, 2025
Update on prevention and antimicrobial prophylaxis of infective endocarditisMaryam Pavlicek-Bahlo, Barbara Hasse, Michelle Frank, et al.
Antibiotics (Basel, Switzerland)|October 25, 2024
Target Attainment and Population Pharmacokinetics of Cefazolin in Patients with Invasive <i>Staphylococcus aureus</i> Infections: A Prospective Cohort StudySeverin Bausch, Sarah Dräger, Panteleimon Charitos-Fragkakis, et al.
Shock (Augusta, Ga.)|February 27, 2019
Heparin-Binding Protein as a Prognostic Biomarker of Sepsis and Disease Severity at the Emergency DepartmentFredrik Kahn, Jonas Tverring, Lisa Mellhammar, et al.
The Journal of Arthroplasty|October 27, 2018
General Assembly, Treatment, Antimicrobials: Proceedings of International Consensus on Orthopedic InfectionsK Keely Boyle, Feng-Chih Kuo, Juan Pablo Horcajada, et al.
Open Forum Infectious Diseases|December 10, 2021
A Multidimensional Cross-Sectional Analysis of Coronavirus Disease 2019 Seroprevalence Among a Police Officer Cohort: The PoliCOV-19 StudyParham Sendi, Rossella Baldan, Marc Thierstein, et al.
Immunity, Inflammation and Disease|June 27, 2022
Serosurveillance after a COVID-19 vaccine campaign in a Swiss police cohortParham Sendi, Marc Thierstein, Nadja Widmer, et al.
Journal of Medical Virology|June 30, 2023
Do quantitative levels of antispike-IgG antibodies aid in predicting protection from SARS-CoV-2 infection? Results from a longitudinal study in a police cohortParham Sendi, Nadja Widmer, Mattia Branca, et al.
Trials|January 5, 2021
Recombinant human C1 esterase inhibitor (conestat alfa) in the prevention of severe SARS-CoV-2 infection in hospitalized patients with COVID-19: A structured summary of a study protocol for a randomized, parallel-group, open-label, multi-center pilot trial (PROTECT-COVID-19)Pascal Urwyler, Panteleimon Charitos, Stephan Moser, et al.
Frontiers in Immunology|November 15, 2023
Recombinant C1 inhibitor in the prevention of severe COVID-19: a randomized, open-label, multi-center phase IIa trialPascal Urwyler, Marina Leimbacher, Panteleimon Charitos, et al.
Antimicrobial Agents and Chemotherapy|July 10, 2020
Effect of Systemic Inflammatory Response to SARS-CoV-2 on Lopinavir and Hydroxychloroquine Plasma ConcentrationsCatia Marzolini, Felix Stader, Marcel Stoeckle, et al.
Pageof 17